Bevacizumab plus chemotherapy for ovarian cancer

被引:0
|
作者
Ozkan, Judy
机构
来源
LANCET ONCOLOGY | 2014年 / 15卷 / 06期
关键词
D O I
10.1016/S1470-2045(14)70142-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:E202 / E202
页数:1
相关论文
共 50 条
  • [31] Bevacizumab in combination with chemotherapy for the treatment of advanced ovarian cancer: a systematic review
    Gerasimos Aravantinos
    Dimitrios Pectasides
    Journal of Ovarian Research, 7
  • [32] Bevacizumab in combination with chemotherapy for the treatment of advanced ovarian cancer: a systematic review
    Aravantinos, Gerasimos
    Pectasides, Dimitrios
    JOURNAL OF OVARIAN RESEARCH, 2014, 7
  • [33] Bevacizumab and ovarian cancer
    Sato, Shinya
    Itamochi, Hiroaki
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2012, 24 (01) : 8 - 13
  • [35] Bevacizumab and ovarian cancer
    Garcia, Agustin
    Singh, Harpreet
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2013, 5 (02) : 133 - 141
  • [36] Bevacizumab in Ovarian Cancer
    Copur, Mehmet S.
    Obermiller, Angela M.
    Ramaekers, Ryan
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (13): : 1256 - 1257
  • [37] BEVACIZUMAB AND OVARIAN CANCER
    Lai, G. G. Y.
    Penson, R. T.
    DRUGS OF TODAY, 2011, 47 (09) : 669 - 681
  • [38] Phase II OVARIO study of niraparib plus bevacizumab therapy in advanced ovarian cancer following front-line platinum-based chemotherapy with bevacizumab
    Hardesty, M. M.
    Krivak, T.
    Wright, G. S.
    Hamilton, E.
    Fleming, E. L.
    Gupta, D.
    Keeton, E.
    Chen, J.
    Clements, A.
    Gray, H. J.
    Konecny, G. E.
    Moore, R. G.
    Richardson, D. L.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 3 - 4
  • [39] Phase II OVARIO Study of niraparib plus bevacizumab therapy in advanced ovarian cancer following front-line platinum-based chemotherapy with bevacizumab
    Hardesty, Melissa
    Krivak, Thomas
    Wright, Gail
    Hamilton, Erika
    Fleming, Evelyn
    Belotte, Jimmy
    Keeton, Erika
    Chen, Jian
    Clements, Aine
    Gray, Heidi
    Konecny, Gottfried
    Moore, Richard
    Richardson, Debra
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S17 - S17
  • [40] Chemotherapy plus bevacizumab versus chemotherapy plus cetuximab as first-line treatment for patients with metastatic colorectal cancer
    Bai, Long
    Wang, Feng
    Li, Zhe-zhen
    Ren, Chao
    Zhang, Dong-sheng
    Zhao, Qi
    Lu, Yun-xin
    Wang, De-shen
    Ju, Huai-qiang
    Qiu, Miao-zhen
    Wang, Zhi-qiang
    Wang, Feng-hua
    Xu, Rui-hua
    MEDICINE, 2016, 95 (51) : e4531